Krishna Vaddi - CEO, Director at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
PRLD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Krishna Vaddi since 11/12/2023

Holdings reported by Krishna Vaddi for Prelude Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.07M $4.02M $3.77 May 25, 2023 Direct
Common Stock 424K $1.6M $3.77 May 24, 2023 By Trust
Common Stock 121K $455K $3.77 May 24, 2023 Indirect
Employee Stock Option (right to buy) 425K Mar 1, 2024 Direct Common Stock

Transactions reported by Krishna Vaddi for Prelude Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.